Can the transfer function method of assessing baroreflex sensitivity predict outcome in heart failure patients?
Andrew L Clark
Correspondence Castle Hill Hospital, Castle Road, Cottingham, Hull HU16 5JQ, UK
Email a.l.clark@hull.ac.uk
This article has no abstract so we have provided the first paragraph of the full text.
CHF due to left ventricular systolic dysfunction remains an enormous clinical problem. This is partly because it is very common—approximately 1% of the population has the condition—and partly because it is, or has been, highly lethal.1 Modern heart failure therapy does, however, offer the chance of approximately doubling life expectancy.2 A major health care challenge is to deliver that therapy to the at-risk population.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
